Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
|
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [21] Emphysematous Gastritis, a Rare Complication in B-Cell Non-Hodgkin Lymphoma After Initiation of R-CHOP Therapy
    Le, M.
    Mohindra, V.
    Gohil, A. A.
    Kirsch, C. M.
    Wu, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma
    T Endo
    N Sato
    Y Mogi
    K Koizumi
    M Nishio
    K Fujimoto
    T Sakai
    K Kumano
    M Obara
    H Ikeda
    T Koike
    Bone Marrow Transplantation, 2004, 33 : 703 - 707
  • [23] Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma
    Endo, T
    Sato, N
    Mogi, Y
    Koizumi, K
    Nishio, M
    Fujimoto, K
    Sakai, T
    Kumano, K
    Obara, M
    Ikeda, H
    Koike, T
    BONE MARROW TRANSPLANTATION, 2004, 33 (07) : 703 - 707
  • [24] Maintenance Rituximab Following R-CHOP Chemotherapy in Patients with Composite or Discordant, Indolent and Aggressive, B-Cell Non-Hodgkin Lymphomas
    Kansara, Roopesh R.
    Connors, Joseph M.
    Savage, Kerry J.
    Scott, David W.
    Gascoyne, Randy D.
    Gerrie, Alina S.
    Sehn, Laurie H.
    Villa, Diego
    BLOOD, 2015, 126 (23)
  • [25] A phase III trial comparing R-CHOP 14 and R-CHOP 21 for the treatment of patients with newly diagnosed diffuse large B-cell non-Hodgkin's lymphoma
    Cunningham, D.
    Smith, P.
    Mouncey, P.
    Qian, W.
    Pocock, C.
    Ardeshna, K. M.
    Radford, J.
    Davies, J.
    McMillan, A.
    Linch, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study)
    Wolff, Thomas
    Schulz, Holger
    Losem, Christoph
    Reichert, Dietmar
    Hurtz, Hans-Juergen
    Sandner, Reiner
    Harde, Johanna
    Grebhardt, Sina
    Potthoff, Karin
    Mueller, Udo
    Fietz, Thomas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (02) : 174 - 181
  • [27] Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support
    Campbell, C
    Sawka, C
    Franssen, E
    Berinstein, NL
    LEUKEMIA & LYMPHOMA, 1999, 35 (1-2) : 119 - 127
  • [28] Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
    Ruth Pettengell
    Hans E. Johnson
    Pieternella J. Lugtenburg
    Antonio Salar Silvestre
    Ulrich Dührsen
    Francesca G. Rossi
    Matthias Schwenkglenks
    Kate Bendall
    Zsolt Szabo
    Ulrich Jaeger
    Supportive Care in Cancer, 2012, 20 : 647 - 652
  • [29] Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
    Pettengell, Ruth
    Johnson, Hans E.
    Lugtenburg, Pieternella J.
    Salar Silvestre, Antonio
    Duehrsen, Ulrich
    Rossi, Francesca G.
    Schwenkglenks, Matthias
    Bendall, Kate
    Szabo, Zsolt
    Jaeger, Ulrich
    SUPPORTIVE CARE IN CANCER, 2012, 20 (03) : 647 - 652
  • [30] INCIDENCE, PREDICTIVE FACTORS, AND INFECTION COMPLICATIONS OF PROLONGED NEUTROPENIA IN R-CHOP/CHOP TREATED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
    Zhou, K. R.
    Kei, K. M.
    Ng, H. M.
    Wong, R. S.
    VALUE IN HEALTH, 2011, 14 (07) : A434 - A435
12345